Obatoclax mesylate (GX15-070MS)

DRUG4 trials

Sponsors

Gemin X

Conditions

Hematological MalignanciesHodgkin's LymphomaMyelodysplastic SyndromesMyelofibrosis

Phase 1

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) for the Treatment of Hematological Malignancies

CompletedNCT00438178

Gemin XHematological Malignancies

Start: 2005-10-31Updated: 2014-05-12

Phase 2

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Myelofibrosis With Myeloid Metaplasia

CompletedNCT00360035

Gemin XMyelofibrosis

Start: 2006-07-31End: 2009-02-28Updated: 2013-08-26

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Hodgkin's Lymphoma

CompletedNCT00359892

Gemin XHodgkin's Lymphoma

Start: 2006-07-31End: 2008-11-30Updated: 2012-08-06

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)for the Treatment of Myelodysplastic Syndromes (MDS)

CompletedNCT00413114

Gemin XMyelodysplastic Syndromes

Start: 2006-12-31End: 2009-11-30Updated: 2013-08-26